In the past few years, new developments on many fronts have created innovation and changes among EMR vendors. Regulations like Meaningful Use have caused particular features and functions to gain sudden prominence. New technologies have given us buzzwords like "software as a service" (SaaS) and "the cloud" -- along with new ways to deliver information. New business models have some EMR companies giving away their product to users. And new hardware like tablets and smartphones are suggesting new ways that clinicians can interact with their EMR systems.
As EMR vendors plan to release new products or new versions of software to take advantage of some of these new opportunities (or to comply with government mandates), it's also the perfect time to evaluate the drug information that forms the basis of any EMRs clinical decision support.
When many EMRs were first designed several years ago, there weren't many choices for drug information. Now there are new vendors in the market with competitive offerings, like Lexicomp. Many new EMRs are finding it to their advantage to sign up with Lexicomp for their drug reference and clinical decision support information. If you've been using the same drug information vendor for years because you thought you had no other choice, it's time to find out why!
As EMR vendors plan to release new products or new versions of software to take advantage of some of these new opportunities (or to comply with government mandates), it's also the perfect time to evaluate the drug information that forms the basis of any EMRs clinical decision support.
When many EMRs were first designed several years ago, there weren't many choices for drug information. Now there are new vendors in the market with competitive offerings, like Lexicomp. Many new EMRs are finding it to their advantage to sign up with Lexicomp for their drug reference and clinical decision support information. If you've been using the same drug information vendor for years because you thought you had no other choice, it's time to find out why!
Comments for Re-evaluating EMR design in a changing market